Carthera

medical devices

About

Carthera is a clinical-stage medtech company based in France, founded in 2010 by Professor Alexandre Carpentier. The company focuses on developing innovative ultrasound-based medical devices to treat severe brain disorders, including glioblastoma and other central nervous system diseases. Carthera's flagship product is the SonoCloud, an intracranial implant that uses low intensity pulsed ultrasound to temporarily open the blood-brain barrier. This technology enhances the delivery of chemotherapy drugs directly to brain tumors, improving treatment efficacy. The company is actively involved in clinical trials and research collaborations to validate and expand the applications of its ultrasound technologies. Carthera serves patients with severe brain diseases, medical institutions, and healthcare providers seeking non-invasive treatment options. The company is committed to advancing its innovative solutions and regularly participates in scientific research and medical conferences.

Technologies

MailJet reCAPTCHA Google Tag Manager WordPress.org YouTube Mobile Friendly Micro

Keywords

medical devices neurosurgery therapeutic ultrasound neurooncology medical equipment manufacturing biotechnology ultrasound resonator ultrasound in neuro-oncology regenerative medicine microbubbles infusion reversible blood-brain barrier opening medical equipment and supplies manufacturing ultrasound therapy brain tumor treatment ultrasound-mediated drug delivery glioblastoma therapy blood-brain barrier opening targeted brain therapy neurotechnology healthcare blood-brain barrier disruption services immunotherapy delivery brain metastases treatment sonocloud implantable device pharmaceuticals ultrasound for cns diseases medical device ultrasound for neurodegenerative diseases implantable ultrasound device

Location

Lyon, Rhone-Alpes, France

Related Companies

Companies in the same industry